Rescheduling Of Marijuana Could Lead To Significant Tax Relief For Cannabis Businesses

TS
Taft Stettinius & Hollister

Contributor

Established in 1885, Taft is a nationally recognized law firm serving individuals and businesses worldwide, in both mature and emerging industries.
The Biden administration's announcement last month that it would move forward with plans to reclassify marijuana from a Schedule I to a Schedule III controlled substance...
United States Cannabis & Hemp
To print this article, all you need is to be registered or login on Mondaq.com.

The Biden administration's announcement last month that it would move forward with plans to reclassify marijuana from a Schedule I to a Schedule III controlled substance could result in significant tax relief for cannabis businesses.

Under current law – specifically, Section 280E of the Internal Revenue Code – no deduction is allowed for any amount paid or incurred during the taxable year in carrying on a trade or business that consists of trafficking in controlled substances within the meaning of Schedule I or Schedule II of the Controlled Substances Act.

In other words, cannabis businesses are not allowed a deduction for ordinary and necessary expenses incurred in the business that would be deductible in virtually any other business – even where the cannabis business is operating in a manner that is legal under state law. As a result, cannabis businesses face effective tax rates much greater than the 21% rate imposed on corporations or even the 37% maximum rate imposed on individuals. Consider the following example:

Regular Business Cannabis Business
Gross Income $1,000,000 $1,000,000
Cost of Goods Sold ($400,000) ($400,000)
Gross Profit $600,000 $600,000
Business Expenses ($400,000) ($400,000)
Net Income $200,000 $200,000
Federal Income Tax (21%) $42,000 $126,000
After-tax Income $158,000 $74,000
Effective Tax Rate 21% 63%


If marijuana ultimately is reclassified as a Schedule III controlled substance, Section 280E of the Code would no longer apply, meaning cannabis businesses could begin deducting their ordinary and necessary expenses to the same extent as other businesses.

The Department of Justice published a proposed rule recommending the reclassification of marijuana from a Schedule I to a Schedule III controlled substance on May 21, 2024. The comment period runs through July 22, 2024, meaning the reclassification could happen within the next several months. If the reclassification occurs in 2024, it may have an effective date of Jan. 1, 2024, meaning cannabis businesses could deduct all ordinary and necessary expenses incurred on and after Jan. 1, 2024.

While it is technically possible that reclassification could be retroactive to prior tax years, there is no indication that it will be. Thus, cannabis businesses likely could not file amended income tax returns or seek relief from taxes incurred in prior years when Section 280E still applied to them.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More